Some studies have shown that angiogenesis, tumor growth and metastasis of breast cancer cells can be inhibited by blocking VEGFR1 and VEGFR2 [132–136], and the expression of bFGF is related to a shorter survival time in patients with tumors [137]. Here, FLT1 is linked to breast cancer.